drugset / Trial / NCT02053350
Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to test the efficacy of alanyl-glutamine supplementation in the treatment of C. difficile infection. We hypothesize that alanyl-glutamine when given with standard antibiotic treatment for C. difficile infection will decrease diarrhea, mortality and recurrent disease.
Timeline
- Start
- 2015-04
- Primary completion
- 2017-04-05
- Completion
- 2017-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alanyl-glutamine | Peptide | 4 g | Oral |
| Subject | Alanyl-glutamine | Peptide | 24 g | Oral |
| Subject | Alanyl-glutamine | Peptide | 44 g | Oral |